Sahajanand Medical Technologies IPO Day 3: GMP at 7%; check subscription status and key details

Sahajanand Medical Technologies’ initial public offering moved into its third day with the grey market premium, or GMP, reported at 7%. The issue had attracted subscription interest equivalent to 82% of the shares available by the close of Day 2.

Subscription status after Day 2

The IPO had 97.50 lakh shares on offer. By the end of the second bidding day, overall subscriptions stood at 82%, leaving the issue below full subscription on the information available before the close of Day 3.

The 82% figure represents the combined subscription position reported for the issue. No further category-wise subscription details are available in the supplied update.

What the 7% GMP indicates

The reported 7% GMP provides the latest grey-market indication associated with the IPO as it entered Day 3. GMP figures are separate from the formal exchange subscription data, so the two figures describe different aspects of the offering.

Key details for investors

Investors tracking the offering have two headline data points from the latest update: the IPO’s overall subscription level was 82% at the end of Day 2, and its reported GMP was 7% on Day 3. The available information does not include the issue price, IPO size, allotment date or listing date.

The subscription and GMP figures may change as bidding progresses. For now, the Day 2 subscription level and Day 3 grey-market indication are the main reported markers for Sahajanand Medical Technologies’ IPO.